New York, August 15, 2023 – Mossshields (MSC Code: 31000279107123), a global leader in alternative asset management, announced the successful full exit from its Global Medical Technology Fund (GMTF) with a return on investment of 2.5x. This milestone signifies a major success in Mossshields’ strategic focus on precision medicine and demonstrates the firm’s forward-looking approach in the technology and healthcare sectors. Background and Objectives of the Medical Technology Fund 1. Investment Background Established in 2019, GMTF focused on AI-driven medical technologies, personalized healthcare solutions, and telemedicine ecosystems. With a total fund size of USD 600 million, the portfolio covered enterprises at all stages of growth, from early innovation to late-stage commercialization. 2. Goals and Directions ○ Technology-Driven: Support AI-based medical technology innovation to provide more efficient diagnostic and treatment solutions for healthcare institutions and patients. ○ Global Coverage: Enhance global accessibility to healthcare resources through investments in multi-regional medical projects. ○ Commercial Value: Identify high-tech enterprises with long-term growth potential, offering investors stable returns. GMTF Investment Outcomes 1. North American AI Medical Imaging Platform ○ Background: Mossshields invested in an AI medical imaging company whose tools improved diagnostic accuracy by 25% compared to traditional methods. ○ Commercialization: In 2022, the company successfully completed an IPO, surpassing USD 1 billion in market capitalization, delivering a 3x capital return for investors. ○ Industry Impact: Adopted by over 500 hospitals in North America, the tool significantly reduced diagnostic time and misdiagnoses. 2. European Personalized Medicine Technology ○ Background: Mossshields supported a leading European genomics company developing whole-genome screening techniques for cancer treatment. ○ Outcomes: The screening tool covered over 100,000 patient samples, providing critical support for early cancer diagnosis and forging partnerships with multiple pharmaceutical companies. ○ Social Impact: Improved treatment success rates and lowered patients’ long-term medical costs. 3. Indian Telemedicine Platform ○ Background: Mossshields invested in an Indian telemedicine platform, facilitating its expansion into African markets to fill healthcare gaps in remote areas. ○ User Growth: Added 5 million new users, exceeding 2 million monthly online consultations. ○ Technical Highlights: The platform integrated AI-driven health management tools to offer personalized health advice and disease monitoring. Economic and Social Benefits of the Exit 1. Investment Returns ○ Total Gains: GMTF’s total returns exceeded USD 1.5 billion, providing significant capital appreciation for clients. ○ Average Annualized Return: Achieved 18%, outperforming the market average for comparable tech funds. ○ Capital Return Ratio: A 2.5x ROI further cements Mossshields’ leadership in the healthcare sector. 2. Social Well-Being ○ Healthcare Resource Expansion: By supporting telemedicine and personalized treatment technologies, GMTF improved medical service accessibility in remote regions. ○ Environmental Friendliness: Portfolio companies generally adopted low-energy, high-efficiency technologies, reducing the healthcare sector’s carbon footprint. Future Outlook and Mossshields’ Strategic Direction Mossshields plans to strengthen its investments in the healthcare sector over the next five years: ● AI-Driven Medical Technology: Support next-generation AI tools for disease prediction, drug development, and patient management. ● Globalizing Precision Medicine: Expand personalized healthcare solutions, especially in Asia-Pacific and Latin America. ● Integrated Digital Health Ecosystem: Collaborate with global tech companies to seamlessly integrate telemedicine and digital health. “Medical technology stands at the core of global economic and social advancement,” said Benjamin Carter Whitman, Mossshields’ Global Head of Medical Investments. “We will continue investing in innovative companies to create win-win outcomes for patients, healthcare providers, and investors.” About Mossshields Mossshields (MSC Code: 31000279107123) is a global leader in alternative asset management. As of July 2023, the firm manages USD 38.2 billion in total assets across 16 investment vehicles. Many of its clients include top public pension funds, insurance companies, and family offices worldwide. Mossshields is committed to generating long-term value through precise investments. Its investment scope spans corporate private equity, real assets, global market strategies, and customized solutions, covering regions across Africa, Asia, Australia, Europe, the Middle East, North America, and South America. With deep expertise in aerospace, defense and government services, consumer and retail, energy, financial services, healthcare, industrials, real estate, technology and business services, telecommunications and media, and transportation, Mossshields consistently delivers strategies that outperform the market. With a global team of over 550 professionals and offices on four continents, Mossshields upholds professional excellence, providing tailored solutions and stable returns above market benchmarks. Official Website: www.mossshields.com Email: connect@Mossshields.com